Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

Overview of the African Medicines Regulatory
Overview of the African Medicines Regulatory
by celsa-spraggs
Harmonization and . African Medicines Agency. Mar...
A n introduction to medicines development and regulation
A n introduction to medicines development and regulation
by jordyn
UKMi Horizon Scanning Working Group. Jim Glare. We...
EUROPEAN MEDICINES AGENCY
EUROPEAN MEDICINES AGENCY
by roberts
ealtEMA Regulatory Science to 2025Strategic rex006...
The Young Statistician's Guide to regulatory statistics
The Young Statistician's Guide to regulatory statistics
by dustin869
Inês Reis – Statistical assessor MHRA. PSI Care...
AIM 2030 Access to Innovative Medicines
AIM 2030 Access to Innovative Medicines
by min-jolicoeur
Draft concept for a new World Bank-led multi-stak...
PhAMA Position on Biosimilar Medicines
PhAMA Position on Biosimilar Medicines
by celsa-spraggs
Ms. Leah Goodman. Contents. Key Messages. An Over...
The Problem of Substandard Medicines in Developing Countries
The Problem of Substandard Medicines in Developing Countries
by cheryl-pisano
By Laura Christian, Linda Collins, . Maythiwan. ...
The Problem of Substandard Medicines in Developing Countries
The Problem of Substandard Medicines in Developing Countries
by pasty-toler
By Laura Christian, Linda Collins, . Maythiwan. ...
WHO Prequalification of Medicines
WHO Prequalification of Medicines
by pamella-moone
Programme. General overview and . update. Dr Mila...
Introduction to regulation of medicines and health technolo
Introduction to regulation of medicines and health technolo
by pamella-moone
Global context of drug regulation. Dr Lembit Räg...
Dr Samvel Azatyan Group Lead
Dr Samvel Azatyan Group Lead
by myesha-ticknor
Capacity Building and Harmonization Support. Regu...
IPC Meeting Agenda - 16
IPC Meeting Agenda - 16
by pasty-toler
to 17 December 2014 . World Bank, Washington DC. ...
Medicines Adaptive Pathways to Patients (MAPPs):
Medicines Adaptive Pathways to Patients (MAPPs):
by debby-jeon
Saving Time, Saving Lives. Thursday, 4 June 2015,...
Dr Samvel Azatyan Group Lead
Dr Samvel Azatyan Group Lead
by lindy-dunigan
Capacity Building and Harmonization Support. Regu...
AFRICA REGULATORY CONFERENCE FEEDBACK
AFRICA REGULATORY CONFERENCE FEEDBACK
by alexa-scheidler
DR DORCAS PETA. 1 JUNE 2012. ACKNOWLEDGEMENT. Thi...
Regulatory capacity building and NDRA approvals of prequali
Regulatory capacity building and NDRA approvals of prequali
by tatyana-admore
products. Milan . Smid. . Prequalification team ...
Regulatory capacity building and NDRA approvals of prequalified
Regulatory capacity building and NDRA approvals of prequalified
by celsa-spraggs
products. Milan . Smid. . Prequalification team ...
Role of Regulation in Optimizing Medicine use
Role of Regulation in Optimizing Medicine use
by yoshiko-marsland
KNH/UON Pharmacy Symposium. Optimizing Medicine u...
The Regulatory Discussion Group
The Regulatory Discussion Group
by tawny-fly
SAPRAA Meeting – 12.09.2014. Bytes Conference C...
European Medicines Agency Veterinary Medicines and Inspections7 Westfe
European Medicines Agency Veterinary Medicines and Inspections7 Westfe
by sherrill-nordquist
The majority of international regulatory authoriti...
AIM 2030
AIM 2030
by mitsue-stanley
Access to Innovative Medicines. Draft concept for...
Post Market Surveillance
Post Market Surveillance
by alida-meadow
KNH/UON . Pharmacy Symposium. Optimizing Medicine...
First Conference of Regulatory Authorities in Sudan and N
First Conference of Regulatory Authorities in Sudan and N
by olivia-moreira
Khartoum, 6-8 December 2014. Dr Lembit Rägo. Hea...
WHO Essential Medicines and Health Products Department
WHO Essential Medicines and Health Products Department
by mitsue-stanley
Update July – Dec. 2015. IPC Meeting, WHO HQ, G...
MPP LICENCES AND OPPORTUNITIES FOR INTRODUCTION OF NEW PRODUCTS AND FORMULATIONS
MPP LICENCES AND OPPORTUNITIES FOR INTRODUCTION OF NEW PRODUCTS AND FORMULATIONS
by cheryl-pisano
Esteban Burrone, . July 2017. THE MEDICINES PATEN...
WHO Prequalification Team – Need and contribution
WHO Prequalification Team – Need and contribution
by debby-jeon
Wednesday, 5 November . 2014. 13:35 – 15:45 . W...
PHARMACY LAW & REGULATORY AFFAIRS
PHARMACY LAW & REGULATORY AFFAIRS
by stefany-barnette
Definitions. Pharmacist.. Licensed Pharmacist.. L...
SADC Collaborative Medicines Registration Process (ZAZIBONA)
SADC Collaborative Medicines Registration Process (ZAZIBONA)
by pamella-moone
Presentation to SAGMA Workshop. 15 August 2016 . ...
WHO Prequalification Team – Need and contribution
WHO Prequalification Team – Need and contribution
by tawny-fly
Wednesday, 5 November . 2014. 13:35 – 15:45 . W...
First Conference of Regulatory Authorities in Sudan and Neighbouring Countries
First Conference of Regulatory Authorities in Sudan and Neighbouring Countries
by tatyana-admore
Khartoum, 6-8 December 2014. Dr Lembit Rägo. Hea...
WHO Prequalification Team – Need and contribution
WHO Prequalification Team – Need and contribution
by alida-meadow
Wednesday, 5 November . 2014. 13:35 – 15:45 . W...
Khin Hnin Pwint 1 , Khin
Khin Hnin Pwint 1 , Khin
by lindy-dunigan
Chit. 2. , Min Wun. 2. , . Myat. Moe Kyi. 2. , ...
First Conference of Regulatory Authorities in Sudan and Neighbouring Countries
First Conference of Regulatory Authorities in Sudan and Neighbouring Countries
by olivia-moreira
Khartoum, 6-8 December 2014. Dr Lembit Rägo. Hea...
The SME Office at the European Medicines Agency
The SME Office at the European Medicines Agency
by majerepr
Constantinos Ziogas. SME Office, Stakeholder &...
en focused on antibiotic therapies is approach has been referred to a
en focused on antibiotic therapies is approach has been referred to a
by eloise
R 5 Nwwwnaturecom/cptnature publishing groupSTATE...
Policy position
Policy position
by maisie
USP Global Public Policy PositionCombatting Substa...
Akinola Akin Adisa
Akinola Akin Adisa
by phoebe
INN Expert Group memberBiographyAkinola Adisa is a...
Manufacturers ' perceptions of
Manufacturers ' perceptions of
by kittie-lecroy
WHO . medicines. . prequalification. Arab . Uni...
WHO PROGRAMME
WHO PROGRAMME
by marina-yarberry
FOR STRENGTHENING . NATIONAL REGULATORY . AUTHORI...
Outreach Sessions 2014
Outreach Sessions 2014
by lindy-dunigan
. Montreal - December 2, 2014. Toronto ...